News Releases

Contrary to the advice most cancer patients receive when they go through radiation treatment, topical skin treatments, unless applied very heavily, do not increase the radiation dose to the skin and can be used in moderation before daily radiation treatments.

Viral vectors used to deliver gene therapies undergo spontaneous changes during manufacturing which affects their structure and function, found researchers from the Perelman School of Medicine at the University of Pennsylvania in a study published in Molecular Therapy.

A team from Penn Medicine that runs a program to improve health outcomes for veterans received a “Gold Status” Diffusion of Excellence award from the Veterans Health Administration (VHA), the health care arm of the United States Department of Veterans Affairs.

In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutations in non-small cell lung cancer (NSCLC), researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone.

Each year, advances make medical devices safer and propel the development of ever-more targeted drugs and precise surgeries. Digital health technology is also emerging as a force to revolutionize patient care.

Kidney stones—solid, pebble-like grit that forms when too much of certain minerals like calcium are in the urine—can strike men, women, and increasingly, children, and the presence and pain of stones afflicts more than 12 percent of the world’s population.

The Cancer Patient Education Network (CPEN) honored the Patient Education Team from Penn Medicine’s OncoLink with the 2018 Excellence in Patient Education Award. The award recognizes individuals or programs that use creative approaches to develop and circulate cancer education to patients and health care professionals. The OncoLink team received the award Friday during the CPEN annual meeting in Atlanta.